Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: Focus on cardiac safety Journal Article


Author: Seidman, A. D.
Article Title: Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: Focus on cardiac safety
Keywords: cancer chemotherapy; controlled study; major clinical study; clinical trial; disease course; note; paclitaxel; cancer patient; follow up; metastasis; controlled clinical trial; medical assessment; multicenter study; cardiotoxicity; breast carcinoma; epirubicin; phase 3 clinical trial; kaplan meier method; echocardiography; heart left ventricle ejection fraction; congestive heart failure; reduction
Journal Title: Breast Diseases: A Year Book Quarterly
Volume: 16
Issue: 1
ISSN: 1043-321X
Publisher: Elsevier Inc.  
Date Published: 2005-04-01
Start Page: 71
End Page: 72
Language: English
DOI: 10.1016/s1043-321x(05)80058-x
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 24 October 2012" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Seidman
    318 Seidman